Michael Farrell

Scopus Author ID ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 42

Top Venues

Addiction (Abingdon, England)

Drug and alcohol review

PLoS medicine

Clinical toxicology (Philadelphia, Pa.)

UNSW Australia

This page only lists publications with an associated author ORCID identifier.

Affiliation History

UNSW Australia Mar 16 2011

Australia

Director :: National Drug and Alcohol Research Centre

Publications

Chrianna Bharat, Ria E Hopkins, Mark S Chambers, Louisa Degenhardt, Amy Peacock, Michael Farrell, Wing See Yuen, Nicola Wing Young Man, Natasa Gisev
Age, period, and cohort trends of substance poisoning, alcohol-related disease, and suicide deaths in Australia, 1980-2019. Social psychiatry and psychiatric epidemiology (2024)
Wayne Denis Hall, Shane Darke, Michael Farrell
Do we need clinical trials of high dose stimulant agonist treatment for stimulant use disorders? Addiction (Abingdon, England) (2024)
Shane Darke, Johan Duflou, Amy Peacock, Michael Farrell, Wayne Denis Hall, Julia M Lappin
A retrospective study of the characteristics and toxicology of cases of lysergic acid diethylamide (LSD)- and psilocybin-related death in Australia. Addiction (Abingdon, England) (2024)
Shane Darke, Johan Duflou, Amy Peacock, Michael Farrell, Wayne Denis Hall, Julia M Lappin
A retrospective study of the characteristics and toxicology of cases of lysergic acid diethylamide (LSD)- and psilocybin-related death in Australia. Addiction (Abingdon, England) 119 (9) (2024)
Wayne Denis Hall, Shane Darke, Michael Farrell
Do we need clinical trials of high dose stimulant agonist treatment for stimulant use disorders? Addiction (Abingdon, England) 119 (4) (2024)
Wayne Denis Hall, Shane Darke, Michael Farrell
Do we need clinical trials of high dose stimulant agonist treatment for stimulant use disorders? Addiction (Abingdon, England) 119 (4) (2024)
Wayne Denis Hall, Shane Darke, Michael Farrell
Do we need clinical trials of high dose stimulant agonist treatment for stimulant use disorders? Addiction (Abingdon, England) 119 (4) (2024)
Shane Darke, Johan Duflou, Amy Peacock, Michael Farrell, Julia M Lappin
A descriptive coronial study of heroin toxicity deaths in Australia, 2020-2022: Characteristics, toxicology and survival times. Addiction (Abingdon, England) (2023)
Beatrice C Downing, Matthew Hickman, Nicola R Jones, Sarah Larney, Michael J Sweeting, Yixin Xu, Michael Farrell, Louisa Degenhardt, Hayley E Jones
Prevalence of opioid dependence in New South Wales, Australia, 2014-16: Indirect estimation from multiple data sources using a Bayesian approach. Addiction (Abingdon, England) (2023)
Chrianna Bharat, Paige Webb, Zachary Wilkinson, Rebecca Mcketin, Jason Grebely, Michael Farrell, Adam Holland, Matthew Hickman, Lucy Thi Tran, Brodie Clark, Amy Peacock, Shane Darke, Jih-Heng Li, Louisa Degenhardt
Agreement between self-reported illicit drug use and biological samples: A systematic review and meta-analysis. Addiction (Abingdon, England) (2023)
Shane Darke, Michael Farrell, Johan Duflou, Julia M Lappin
Chronic obstructive pulmonary disease in heroin users: An underappreciated issue with clinical ramifications. Addiction (Abingdon, England) (2023)
Thomas D Brothers, Dan Lewer, Nicola R Jones, Samantha Colledge-Frisby, Michael Farrell, Matthew Hickman, Duncan Webster, Andrew C Hayward, Louisa Degenhardt
Opioid agonist treatment and risk of death or rehospitalization following injection drug use-associated bacterial and fungal infections: A cohort study in New South Wales, Australia. PLoS medicine 19 (7) (2022)
Emma Black, Kristie Mammen, Rachel M Deacon, Nadine Ezard, Llewellyn Mills, Melissa A Jackson, Mark E Montebello, David Reid, Steven Childs, Raimondo Bruno, Anthony P Shakeshaft, Krista J Siefried, Michael Farrell, Jennifer Holmes, Nicholas Lintzeris
Health and social characteristics of clients reporting amphetamine type substance use at entry to public alcohol and other drug services in New South Wales, Australia, 2016-2019. Drug and alcohol review 42 (2) (2022)
Emma Black, Kristie Mammen, Rachel M Deacon, Nadine Ezard, Llewellyn Mills, Melissa A Jackson, Mark E Montebello, David Reid, Steven Childs, Raimondo Bruno, Anthony P Shakeshaft, Krista J Siefried, Michael Farrell, Jennifer Holmes, Nicholas Lintzeris
Health and social characteristics of clients reporting amphetamine type substance use at entry to public alcohol and other drug services in New South Wales, Australia, 2016-2019. Drug and alcohol review 42 (2) (2022)
Emma Black, Kristie Mammen, Rachel M Deacon, Nadine Ezard, Llewellyn Mills, Melissa A Jackson, Mark E Montebello, David Reid, Steven Childs, Raimondo Bruno, Anthony P Shakeshaft, Krista J Siefried, Michael Farrell, Jennifer Holmes, Nicholas Lintzeris
Health and social characteristics of clients reporting amphetamine type substance use at entry to public alcohol and other drug services in New South Wales, Australia, 2016-2019. Drug and alcohol review (2022)
Wing See Yuen, Amy Peacock, Nicola Man, Sarah Callinan, Tim Slade, Michael Farrell, Richard Mattick, Michael Livingston
Age, period and cohort effects on alcohol-related risky behaviours in Australia from 2001 to 2016. Addiction (Abingdon, England) (2022)
Shane Darke, Johan Duflou, Amy Peacock, Agata Chrzanowska, Michael Farrell, Julia M Lappin
Rates, characteristics and toxicology of cocaine-related deaths in Australia, 2000-2021. Addiction (Abingdon, England) (2022)
Emma Black, Kristie Mammen, Rachel M Deacon, Nadine Ezard, Llewellyn Mills, Melissa A Jackson, Mark E Montebello, David Reid, Steven Childs, Raimondo Bruno, Anthony P Shakeshaft, Krista J Siefried, Michael Farrell, Jennifer Holmes, Nicholas Lintzeris
Health and social characteristics of clients reporting amphetamine type substance use at entry to public alcohol and other drug services in New South Wales, Australia, 2016-2019. Drug and alcohol review 42 (2) (2022)
Wayne Denis Hall, Michael Farrell
Aldous Huxley's The Doors of Perception. Addiction (Abingdon, England) (2021)
Dan Lewer, Brian Eastwood, Martin White, Thomas D Brothers, Martin McCusker, Caroline S Copeland, Michael Farrell, Irene Petersen
Fatal opioid overdoses during and shortly after hospital admissions in England: A case-crossover study. PLoS medicine 18 (10) (2021)
Wing See Yuen, Gary Chung Kai Chan, Raimondo Bruno, Philip James Clare, Alexandra Aiken, Richard Mattick, Michael Farrell, Kypros Kypri, Tim Slade, Delyse Hutchinson, Nyanda McBride, Jim McCambridge, Veronica C Boland, Amy Peacock
Trajectories of alcohol-induced blackouts in adolescence: early risk factors and alcohol use disorder outcomes in early adulthood. Addiction (Abingdon, England) 116 (8) (2021)
Donald Weatherburn, Shane Darke, Emma Zahra, Michael Farrell
Who would try (or use more) cannabis if it were legal? Drug and alcohol review (2021)
Antoine Chaillon, Chrianna Bharat, Jack Stone, Nicola Jones, Louisa Degenhardt, Sarah Larney, Michael Farrell, Peter Vickerman, Matthew Hickman, Natasha K Martin, Annick Borquez
Modeling the population-level impact of opioid agonist treatment on mortality among people accessing treatment between 2001 and 2020 in New South Wales, Australia. Addiction (Abingdon, England) (2021)
Shane Darke, Johan Duflou, Amy Peacock, Michael Farrell, Julia M Lappin
Characteristics of fatal gabapentinoid-related poisoning in Australia, 2000-2020. Clinical toxicology (Philadelphia, Pa.) (2021)
Rachel M Deacon, Kristie Mammen, Raimondo Bruno, Llewellyn Mills, Adrian Dunlop, Jennifer Holmes, Meryem Jefferies, Michelle Hall, Anthony Shakeshaft, Michael Farrell, Robert Graham, Nicholas Lintzeris
Assessing the concurrent validity, inter-rater reliability and test-re-test reliability of the Australian Treatment Outcomes Profile (ATOP) in alcohol and opioid treatment populations. Addiction (Abingdon, England) 116 (5) (2021)
Nicola Wing Young Man, Agata Chrzanowska, Olivia H Price, Raimondo Bruno, Paul M Dietze, Scott A Sisson, Louisa Degenhardt, Caroline L Salom, Leith Morris, Michael Farrell, Amy Peacock
Trends in cocaine use, markets and harms in Australia, 2003-2019. Drug and alcohol review 40 (6) (2021)
Wayne Denis Hall, Michael Farrell
What can we learn from the history of research on psychedelic drugs in the addictions? Addiction (Abingdon, England) 116 (11) (2021)
Rebecca Mcketin, Michael Farrell
When the evidence is not enough: is it time to rethink trial design? Addiction (Abingdon, England) 116 (4) (2020)
Shane Darke, Johan Duflou, Michael Farrell, Amy Peacock, Julia M Lappin
Characteristics and circumstances of death related to the self-administration of ketamine. Addiction (Abingdon, England) 116 (2) (2020)
Michael Farrell, Roy Robertson
Commentary on Ho et al. (2020): Managing people with HIV and drug problems is complex and multi-faceted. Addiction (Abingdon, England) 115 (4) (2020)
Ashleigh Guillaumier, Eliza Skelton, Anthony Shakeshaft, Michael Farrell, Flora Tzelepis, Scott Walsberger, Catherine D'Este, Christine Paul, Adrian Dunlop, Robert Stirling, Carrie Fowlie, Peter Kelly, Christopher Oldmeadow, Kerrin Palazzi, Billie Bonevski
Effect of increasing the delivery of smoking cessation care in alcohol and other drug treatment centres: a cluster-randomized controlled trial. Addiction (Abingdon, England) 115 (7) (2020)
Suzanne Nielsen, Paul Sanfilippo, Vendula Belackova, Carolyn A Day, Edmund Silins, Nicholas Lintzeris, Raimondo Bruno, Jason Grebely, Kari Lancaster, Robert Ali, James Bell, Paul Dietze, Louisa Degenhardt, Michael Farrell, Briony Larance
Perceptions of injectable opioid agonist treatment (iOAT) among people who regularly use opioids in Australia: findings from a cross-sectional study in three Australian cities. Addiction (Abingdon, England) 116 (6) (2020)
Briony Larance, Louisa Degenhardt, Jason Grebely, Suzanne Nielsen, Raimondo Bruno, Paul M Dietze, Kari Lancaster, Sarah Larney, Thomas Santo, Marian Shanahan, Sonja Memedovic, Robert L Ali, Michael Farrell
Perceptions of extended-release buprenorphine injections for opioid use disorder among people who regularly use opioids in Australia. Addiction (Abingdon, England) 115 (7) (2020)
Amy Peacock, Briony Larance, Raimondo Bruno, Sallie-Anne Pearson, Nicholas A Buckley, Michael Farrell, Louisa Degenhardt
Effectiveness and framing of pharmaceutical opioid abuse-deterrent formulations. Addiction (Abingdon, England) 114 (3) (2019)
Dennis Thomas, Michael Farrell, Hayden McRobbie, Piotr Tutka, Dennis Petrie, Robert West, Mohammad Siahpush, Coral E Gartner, Natalie Walker, Colin P Mendelsohn, Wayne Denis Hall, Christine Paul, Nicholas Zwar, Stuart G Ferguson, Veronica C Boland, Robyn Richmond, Christopher M Doran, Anthony Shakeshaft, Richard P Mattick, Ryan J Courtney
The effectiveness, safety and cost-effectiveness of cytisine versus varenicline for smoking cessation in an Australian population: a study protocol for a randomized controlled non-inferiority trial. Addiction (Abingdon, England) 114 (5) (2019)
Suzanne Nielsen, Sarah Larney, Michael Farrell
Commentary on McDonald et al. (2018): Intranasal naloxone-from the laboratory to the real world. Addiction (Abingdon, England) 113 (3) (2019)
Shane Darke, Michael Farrell, Johan Duflou, Briony Larance, Julia M Lappin
Circumstances of death of opioid users being treated with naltrexone. Addiction (Abingdon, England) 114 (11) (2019)
Emily A Stockings, Lucy Thi Tran, Thomas Santo, Amy Peacock, Sarah Larney, Damian Francesco Santomauro, Michael Farrell, Louisa Degenhardt
Mortality among people with regular or problematic use of amphetamines: a systematic review and meta-analysis. Addiction (Abingdon, England) 114 (10) (2019)
Amy Peacock, Janni K Y Leung, Sarah Larney, Samantha Colledge, Matthew Hickman, Jürgen Rehm, Gary A Giovino, Robert West, Wayne Denis Hall, Paul Griffiths, Robert L Ali, Linda R Gowing, John Marsden, Alize J Ferrari, Jason Grebely, Michael Farrell, Louisa Degenhardt
Global statistics on alcohol, tobacco and illicit drug use: 2017 status report. Addiction (Abingdon, England) 113 (10) (2018)
Jason Grebely, Sarah Larney, Amy Peacock, Samantha Colledge-Frisby, Janni K Y Leung, Matthew Hickman, Peter Vickerman, Sarah Blach, Evan B Cunningham, Konstantin Dumchev, Michael T Nurmohamed, Jack Stone, Adam Trickey, Homie Razavi, Richard P Mattick, Michael Farrell, Gregory J Dore, Louisa Degenhardt
Global, regional, and country-level estimates of hepatitis C infection among people who have recently injected drugs. Addiction (Abingdon, England) 114 (1) (2018)
Shane Darke, Michael Farrell
Burroughs' 'Letter from a master addict to dangerous drugs': a forgotten classic. Addiction (Abingdon, England) 113 (12) (2018)
Amy Peacock, Briony Larance, Raimondo Bruno, Sallie-Anne Pearson, Nicholas A Buckley, Michael Farrell, Louisa Degenhardt
Post-marketing studies of pharmaceutical opioid abuse-deterrent formulations: a framework for research design and reporting. Addiction (Abingdon, England) 114 (3) (2018)

Michael Farrell.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Michael Farrell